Sudhanva Hegde, MD
Interventional Cardiology · Brooklyn, NYNPI 1558559989
Payments from drug & device makers
Across 203 payments — averaging $42.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$2K
- Inari Medical, Inc.$869
- Abbott$741
- Medtronic$679
- Kestra Medical Technology Services, Inc.$634
- Abiomed$584
- plus $3K from 29 others
What the payments were for
- Travel & lodging$7489%
- Food & beverage$7,82691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 14 | $1,642 |
| Inari Medical, Inc. | 19 | $869 |
| Abbott | 16 | $741 |
| Medtronic | 7 | $679 |
| Kestra Medical Technology Services, Inc. | 8 | $634 |
| Abiomed | 16 | $584 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $358 |
| Philips North America LLC | 8 | $316 |
| Novartis | 13 | $315 |
| Johnson & Johnson | 12 | $304 |
| CSL Behring | 8 | $239 |
| Stryker | 2 | $229 |
| Penumbra, Inc. | 7 | $227 |
| Irhythm Technologies, Inc. | 3 | $164 |
| E.r. Squibb & Sons, L.L.C. | 11 | $164 |
| Terumo Medical Corporation | 3 | $133 |
| Boston Scientific | 5 | $128 |
| Pfizer | 5 | $110 |
| Boehringer Ingelheim | 4 | $96 |
| Angiodynamics, Inc. | 2 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $68 |
| AstraZeneca | 3 | $65 |
| Teleflex LLC | 3 | $59 |
| Convatec Inc. | 3 | $54 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Merck | 2 | $39 |
| Chiesi USA, Inc. | 2 | $37 |
| Edwards Lifesciences | 1 | $37 |
| Acarix USA Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Asahi Intecc USA, Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,574 in reported general payments places this provider in the 45th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Brooklyn
- Jamie MengBrooklyn$1.8M
- Peter RouvelasBrooklyn$332K
- Yuhei KobayashiBrooklyn$246K
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.